- Home
- PRKS vs WGS Comparison
PRKS vs WGS Comparison
Compare PRKS & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRKS | WGS |
|---|---|---|
| Founded | 1959 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRKS | WGS |
|---|---|---|
| Price | $36.19 | $164.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | $52.09 | ★ $130.63 |
| AVG Volume (30 Days) | ★ 1.7M | 514.5K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.27 | 0.07 |
| Revenue | ★ $1,673,396,000.00 | $402,190,000.00 |
| Revenue This Year | $0.79 | $39.54 |
| Revenue Next Year | $2.42 | $22.50 |
| P/E Ratio | ★ $11.05 | $2,316.67 |
| Revenue Growth | N/A | ★ 50.50 |
| 52 Week Low | $29.62 | $55.17 |
| 52 Week High | $60.83 | $170.75 |
Technical Indicators
Market Signals| Indicator | PRKS | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 42.16 | 73.47 |
| Support Level | $29.62 | $119.43 |
| Resistance Level | $33.07 | $170.75 |
| Average True Range (ATR) | 1.64 | 9.18 |
| MACD | 0.73 | 3.28 |
| Stochastic Oscillator | 87.95 | 90.10 |
Price Performance
Historical ComparisonAbout PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.